Latvia vs Poland: Previously treated cases tested for RR-/MDR-TB
Latvia
80.0%
in 2022
Poland
80.0%
in 2024
Latvia rank
114th
Poland rank
114th
Previously treated cases tested for RR-/MDR-TB over time
- Latvia
- Poland
How they compare
Latvia currently reports 80.0% against 80.0% in Poland, a difference of 0.0%.
The two have swapped places 1 time across 13 shared years of data; in 2007 it was Latvia ahead.
Latvia ranks 114th and Poland ranks 114th of 180 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.3% | 53.3% | 40.0% | Latvia |
| 2010s | 88.1% | 60.5% | 27.6% | Latvia |
| 2020s | 86.0% | 83.0% | 3.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Latvia or Poland?
- Latvia, at 80.0% against 80.0% in Poland as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Latvia and Poland?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Poland?
- 13 years are reported by both, from 2007 to 2022.
- How do Latvia and Poland rank globally for previously treated cases tested for rr-/mdr-tb?
- Latvia ranks 114th and Poland ranks 114th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.